Literature DB >> 36271963

Challenges in osteoporosis treatment initiation in geriatric patients admitted under the hip-fracture pathway.

Angela Frances Yap Hui Wen1, Bernard Yap Kok Chong2, Lissa Vazhayil Joseph3, Joyce Koh Suang Bee3, Howe Tet Sen3, Kaysar Mamun4.   

Abstract

Osteoporosis is often untreated especially in older people. This study found a low prescribing rate of osteoporosis treatment medication of 22.4% in older people admitted under the hip-fracture pathway. Factors associated with greater odds of being prescribed osteoporosis medications are categorized into patient-related, physician-related and system-related factors.
INTRODUCTION: Osteoporosis represents a growing healthcare problem which is often overlooked by healthcare providers and untreated especially in older people. This study aims to assess the rate of osteoporosis treatment initiation and to investigate underlying physician and system-related barriers in geriatric patients admitted for hip fracture.
METHODS: A retrospective study was conducted on patients aged 60 years and older, admitted under the hip-fracture pathway from January 2019 to December 2019. Data collected included demographics, co-morbid conditions and laboratory data. Clinical charts were reviewed for whether bone mineral density (BMD) scan has been ordered, plans for bone health were made and reflected in the discharge summary, and if appropriate memos were written. The primary outcome was the prescription of osteoporosis treatment medications. Prescription lists were also reviewed for prescribing patterns of calcium and vitamin D.
RESULTS: A total of 375 patients older than 60 years old were identified. 281 patients who fit the inclusion and exclusion criteria with complete data were further analysed. Within 1 year of hip fracture admission, 63 (22.4%) of them were prescribed with osteoporosis treatment. Multivariate logistic regression identified milder stage of CKD (p = 0.038, OR = 0.617, 95% CI 0.392-0.973) and BMD scan performed (p < 0.001, OR = 6.515, 95% CI 3.180-13.348) as independent factors associated with the prescription of osteoporosis treatment within 1 year of hip fracture admission.
CONCLUSION: The rate of osteoporosis treatment initiation post-hip fracture is low. Systematic solutions will need to be established to ensure that osteoporosis treatment is addressed prior to discharge.
© 2022. International Osteoporosis Foundation and Bone Health and Osteoporosis Foundation.

Entities:  

Keywords:  Geriatric patients; Hip-fracture pathway; Osteoporosis treatment

Year:  2022        PMID: 36271963     DOI: 10.1007/s11657-022-01179-6

Source DB:  PubMed          Journal:  Arch Osteoporos            Impact factor:   2.879


  21 in total

1.  Use of osteoporosis medications after hospitalization for hip fracture: a cross-national study.

Authors:  Seoyoung C Kim; Mi-Sook Kim; Gabriel Sanfélix-Gimeno; Hong Ji Song; Jun Liu; Isabel Hurtado; Salvador Peiró; Joongyub Lee; Nam-Kyong Choi; Byung-Joo Park; Jerry Avorn
Journal:  Am J Med       Date:  2015-02-03       Impact factor: 4.965

Review 2.  An overview and management of osteoporosis.

Authors:  Tümay Sözen; Lale Özışık; Nursel Çalık Başaran
Journal:  Eur J Rheumatol       Date:  2016-12-30

Review 3.  Quality health care gaps in osteoporosis: how can patients, providers, and the health system do a better job?

Authors:  Gim Gee Teng; Jeffrey R Curtis; Kenneth G Saag
Journal:  Curr Osteoporos Rep       Date:  2009-03       Impact factor: 5.096

4.  Association of Osteoporosis Medication Use After Hip Fracture With Prevention of Subsequent Nonvertebral Fractures: An Instrumental Variable Analysis.

Authors:  Rishi J Desai; Mufaddal Mahesri; Younathan Abdia; Julie Barberio; Angela Tong; Dongmu Zhang; Panagiotis Mavros; Seoyoung C Kim; Jessica M Franklin
Journal:  JAMA Netw Open       Date:  2018-07-06

5.  Improvement in the undertreatment of osteoporosis following hip fracture.

Authors:  Michael J Gardner; Kyle R Flik; Pekka Mooar; Joseph M Lane
Journal:  J Bone Joint Surg Am       Date:  2002-08       Impact factor: 5.284

6.  Denosumab for prevention of fractures in postmenopausal women with osteoporosis.

Authors:  Steven R Cummings; Javier San Martin; Michael R McClung; Ethel S Siris; Richard Eastell; Ian R Reid; Pierre Delmas; Holly B Zoog; Matt Austin; Andrea Wang; Stepan Kutilek; Silvano Adami; Jose Zanchetta; Cesar Libanati; Suresh Siddhanti; Claus Christiansen
Journal:  N Engl J Med       Date:  2009-08-11       Impact factor: 91.245

7.  Factors influencing diagnosis and treatment of osteoporosis after a fragility fracture among postmenopausal women in Asian countries: a retrospective study.

Authors:  Annie W Kung; Tao Fan; Ling Xu; Wei B Xia; Il Hyung Park; Hak Sun Kim; Siew Pheng Chan; Joon Kiong Lee; Leonard Koh; Yung Kuei Soong; Suppasin Soontrapa; Thawee Songpatanasilp; Thana Turajane; Marc Yates; Shuvayu Sen
Journal:  BMC Womens Health       Date:  2013-02-14       Impact factor: 2.809

8.  Closing the osteoporosis care gap in hip fracture patients: an opportunity to decrease recurrent fractures and hospital admissions.

Authors:  Anna Byszewski; Genevieve Lemay; Frank Molnar; Nahid Azad; Seanna E McMartin
Journal:  J Osteoporos       Date:  2011-09-29

9.  Reducing mortality from hip fractures: a systematic quality improvement programme.

Authors:  Radcliffe Lisk; Keefai Yeong
Journal:  BMJ Qual Improv Rep       Date:  2014-09-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.